Cargando…

Approaching Neoadjuvant Therapy in the Management of Early-Stage Breast Cancer

Neoadjuvant therapy is integral to the treatment of early-stage breast cancer. Goals of treatment include surgical downstaging of the tumor, rendering inoperable tumors resectable, and de-escalating axillary surgery in those with clinically positive nodes. Additionally, response to treatment provide...

Descripción completa

Detalles Bibliográficos
Autores principales:	Hyder, Tara, Bhattacharya, Saveri, Gade, Kristine, Nasrazadani, Azadeh, Brufsky, Adam M
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Dove 2021
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8019614/ https://www.ncbi.nlm.nih.gov/pubmed/33833568 http://dx.doi.org/10.2147/BCTT.S273058

Ejemplares similares

Statins and endocrine resistance in breast cancer
por: Hyder, Tara, et al.
Publicado: (2021)

Aromatase Inhibitor-Associated Musculoskeletal Syndrome: Understanding Mechanisms and Management
por: Hyder, Tara, et al.
Publicado: (2021)

Artificial intelligence-directed prognostication of breast cancer
por: Nasrazadani, Azadeh, et al.
Publicado: (2019)

Personalising therapy for early-stage oestrogen receptor-positive breast cancer in older women
por: Carleton, Neil, et al.
Publicado: (2022)

Twenty-Year Follow-Up of a Phase II Trial of Taxotere/Carboplatin/Herceptin in Patients With Metastatic HER2-Positive Breast Cancer
por: Gomez Marti, Juan Luis, et al.
Publicado: (2023)

Ovarian function suppression as a potential mechanism of chemotherapy
por: Gomez Marti, Juan Luis, et al.
Publicado: (2021)

Boning up: amino-bisphophonates as immunostimulants and endosomal disruptors of dendritic cell in SARS-CoV-2 infection
por: Brufsky, Adam, et al.
Publicado: (2020)

Breast cancer mortality as a function of age
por: Nasrazadani, Azadeh, et al.
Publicado: (2022)

Voltage-Gated Calcium Channel Antibody-Induced Oropharyngeal Dysphagia Presenting as a Paraneoplastic Neurological Complication in Breast Cancer
por: Khanam, Razwana, et al.
Publicado: (2021)

Persistence to extended adjuvant endocrine therapy following Breast Cancer Index (BCI) testing in women with early-stage hormone receptor-positive (HR +) breast cancer
por: Foldi, Julia, et al.
Publicado: (2023)

Neoadjuvant therapy for early-stage breast cancer: the clinical utility of pertuzumab
por: Gollamudi, Jahnavi, et al.
Publicado: (2016)

Neoadjuvant approach in patients with early breast cancer: patient assessment, staging, and planning()
por: Rubio, Isabel T., et al.
Publicado: (2021)

Diagnostics and Therapeutics in Early Stage Breast Cancer Receiving Neoadjuvant Systemic Therapy
por: Belli, Paolo, et al.
Publicado: (2023)

Precision Medicine in Hormone Receptor-Positive Breast Cancer
por: Nasrazadani, Azadeh, et al.
Publicado: (2018)

Neoadjuvant immunotherapy in early-stage triple negative breast cancer
por: Laouris, Panayiotis, et al.
Publicado: (2023)

Current Approaches and Emerging Directions in HER2-resistant Breast Cancer
por: Brufsky, Adam M
Publicado: (2014)

Neoadjuvant endocrine therapy use in early stage breast cancer during the covid-19 pandemic
por: Park, Ko Un, et al.
Publicado: (2021)

Predicting the response to neoadjuvant therapy for early-stage breast cancer: tumor-, blood-, and imaging-related biomarkers
por: Tan, Wenyong, et al.
Publicado: (2018)

Optimal approach in early breast cancer: Adjuvant and neoadjuvant treatment
por: Ribeiro, J., et al.
Publicado: (2013)

Prognostic utility of the breast cancer index and comparison to Adjuvant! Online in a clinical case series of early breast cancer
por: Jankowitz, Rachel C, et al.
Publicado: (2011)

Current treatment of early breast cancer: adjuvant and neoadjuvant therapy
por: Miller, Elizabeth, et al.
Publicado: (2014)

Neoadjuvant Endocrine Therapy in Breast Cancer Management: State of the Art
por: Lerebours, Florence, et al.
Publicado: (2021)

Neoadjuvant radiotherapy of early-stage breast cancer and long-term disease-free survival
por: Poleszczuk, Jan, et al.
Publicado: (2017)

The Dual Blockade in the Neoadjuvant Setting of HER-2 Positive Early-Stage Breast Cancer
por: Pop, Lucian, et al.
Publicado: (2019)

Early Imaging and Molecular Changes with Neoadjuvant Bevacizumab in Stage II/III Breast Cancer
por: López-Vega, José Manuel, et al.
Publicado: (2021)

EVI1 expression in early-stage breast cancer patients treated with neoadjuvant chemotherapy
por: Leichsenring, Jonas, et al.
Publicado: (2022)

Ganitumab and metformin plus standard neoadjuvant therapy in stage 2/3 breast cancer
por: Yee, Douglas, et al.
Publicado: (2021)

A Predictor of Pathological Complete Response to Neoadjuvant Chemotherapy Stratifies Triple Negative Breast Cancer Patients with High Risk of Recurrence
por: Fournier, Marcia V., et al.
Publicado: (2019)

nab-Paclitaxel for the treatment of breast cancer: an update across treatment settings
por: Brufsky, Adam
Publicado: (2017)

Treatment Strategies for Residual Disease following Neoadjuvant Chemotherapy in Patients with Early-Stage Breast Cancer
por: Abdel-Razeq, Hikmat, et al.
Publicado: (2022)

Evaluation of multigene assays as predictors for response to neoadjuvant chemotherapy in early-stage breast cancer patients
por: Freeman, Jincong Q., et al.
Publicado: (2023)

The impact of race and age on response to neoadjuvant therapy and long-term outcomes in Black and White women with early-stage breast cancer
por: Terman, Elizabeth, et al.
Publicado: (2023)

The Impact of Race and Age on Response to Neoadjuvant Therapy and Long-Term Outcomes in Black and White Women with Early-Stage Breast Cancer
por: Terman, Elizabeth, et al.
Publicado: (2023)

Outcomes of a Multidisciplinary Team in the Management of Patients with Early-Stage Breast Cancer Undergoing Neoadjuvant Chemotherapy at a Community Cancer Center
por: Bhardwaj, Prarthna V., et al.
Publicado: (2023)

Neoadjuvant systemic therapy for breast cancer
por: Zaborowski, Alexandra M, et al.
Publicado: (2023)

Estradiol as a Targeted, Late-Line Therapy in Metastatic Breast Cancer with Estrogen Receptor Amplification
por: Kota, Karthik, et al.
Publicado: (2017)

Rapid response of breast cancer to neoadjuvant intramammary testosterone-anastrozole therapy: neoadjuvant hormone therapy in breast cancer
por: Glaser, Rebecca L., et al.
Publicado: (2014)

Using Oncotype DX breast recurrence score® assay to define the role of neoadjuvant endocrine therapy in early-stage hormone receptor-positive breast cancer
por: Taylor, Caitlin, et al.
Publicado: (2023)

Multidisciplinary Approach to Neoadjuvant Endocrine Therapy in Breast Cancer: A Comprehensive Review
por: Reinert, Tomás, et al.
Publicado: (2016)

Effect of Neoadjuvant Chemotherapy on the Serum Levels of Bone Turnover Markers in Women with Early-Stage Breast Cancer
por: Chen, YangYang, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_3mbsnh2m9e88a0t2cbplgkv2lp